Currently, vaccines developed by AstraZeneca, Pfizer and others are a hot issue, but in the first half of last year, Remdesivir was ranked first as a keyword related to COVID-19.

Gilead, the developer of Veklury (Remdesivir), is a pharmaceutical company specializing in antiviral drugs. It is leading and has pipelines in a variety of fields, from hepatitis B and C to HIV.
Last year, the company is expanding its anticancer treatment portfolio by acquiring Forty Seven, an anticancer drug company, and Immunomedics, an ADC development company. This is the story of Lee Seung-woo ( 64 years old), CEO of Gilead, who has both'the original good and the latest trend' like killing two birds with one stone, c